The UK's Medicines and Healthcare products Regulatory Agency (MHRA) published two reports on 12 June 2026 detailing patient and professional views on artificial intelligence in healthcare. Based on 760 submissions from a public Call for Evidence, the findings will guide the independent National Commission into the Regulation of AI in Healthcare and define future safety frameworks for clinical AI deployment.
Public priorities for AI deployment
Stakeholders including patients, healthcare professionals, researchers, and industry representatives participated in the consultation. Participants acknowledged the potential benefits of AI across diagnostics, clinical decision support, and administrative tasks. However, they emphasized that safety, effectiveness, transparency, and accountability must remain central to any deployment strategy.
Core regulatory demands
Several consistent priorities emerged from the engagement process. Respondents called for ongoing monitoring of AI systems after deployment. They also demanded transparent decision-making processes and clear accountability mechanisms. Human oversight remains a non-negotiable requirement for the majority of contributors. Many also argued that regulatory frameworks must adapt to technological advances without compromising patient protections.
Upcoming regulatory guidance
These findings will directly inform recommendations expected later in 2026 from the National Commission into the Regulation of AI in Healthcare. The MHRA and other health authorities will use these recommendations to guide future regulatory decisions. Professionals working in AI for Healthcare should anticipate stricter oversight mechanisms as these frameworks develop. Additionally, organizations developing or deploying these tools may find value in understanding the AI Learning Path for Regulatory Affairs Specialists to ensure compliance with upcoming standards.
Why this matters for healthcare professionals
Public support for healthcare AI depends directly on transparency and human oversight. As adoption accelerates, healthcare professionals will face increased scrutiny regarding how they implement and monitor AI tools. Clinicians and administrators must prepare for adaptive regulatory frameworks that demand continuous post-deployment evaluation and documented human oversight in clinical workflows.
Your membership also unlocks:
